IPG Investment Advisors’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.4K | Hold |
12,500
| – | – | 0.01% | 176 |
|
|
2025
Q1 | $7.95K | Hold |
12,500
| – | – | ﹤0.01% | 169 |
|
|
2024
Q4 | $12.9K | Hold |
12,500
| – | – | ﹤0.01% | 173 |
|
|
2024
Q3 | $14.8K | Hold |
12,500
| – | – | ﹤0.01% | 172 |
|
|
2024
Q2 | $15.3K | Hold |
12,500
| – | – | ﹤0.01% | 173 |
|
|
2024
Q1 | $27.3K | Hold |
12,500
| – | – | 0.01% | 165 |
|
|
2023
Q4 | $19.4K | Buy |
+12,500
| New | +$19.4K | ﹤0.01% | 189 |
|
|
2023
Q3 | – | Sell |
-12,500
| Closed | -$21.5K | – | 163 |
|
|
2023
Q2 | $21.5K | Hold |
12,500
| – | – | ﹤0.01% | 167 |
|
|
2023
Q1 | $18.9K | Hold |
12,500
| – | – | ﹤0.01% | 160 |
|
|
2022
Q4 | $20K | Hold |
12,500
| – | – | 0.01% | 134 |
|
|
2022
Q3 | $18.1K | Hold |
12,500
| – | – | 0.01% | 136 |
|
|
2022
Q2 | $23K | Hold |
12,500
| – | – | 0.01% | 150 |
|
|
2022
Q1 | $33K | Hold |
12,500
| – | – | 0.01% | 163 |
|
|
2021
Q4 | $55K | Hold |
12,500
| – | – | 0.01% | 198 |
|
|
2021
Q3 | $63.6K | Hold |
12,500
| – | – | 0.02% | 126 |
|
|
2021
Q2 | $79.1K | Buy |
+12,500
| New | +$79.1K | 0.02% | 135 |
|